Related Experiment Video
Updated: Aug 6, 2026

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice
Published on: February 18, 2015
Risk factors for esophageal candidiasis
A Chocarro Martínez1, F Galindo Tobal, G Ruiz-Irastorza
1Department of Internal Medicine, Hospital Virgen de la Concha, Zamora, Spain. achocarrom@medynet.com
Gastric acid inhibitors like omeprazole, along with antibiotics and steroids, are linked to increased risk of Candida esophagitis in patients with chronic diseases. This suggests omeprazole may promote esophageal candidiasis development.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Pharmacology
Background:
- The role of gastric acid inhibitors in predisposing individuals to Candida esophagitis remains unclear.
- Candida esophagitis is a significant opportunistic infection, particularly in immunocompromised or debilitated patients.
Purpose of the Study:
- To investigate the potential role of gastric acid inhibitors, specifically omeprazole, as predisposing factors for Candida esophagitis.
- To identify risk factors associated with the development of esophageal candidiasis in human immunodeficiency virus (HIV)-negative patients.
Main Methods:
- A retrospective case-control study was conducted involving HIV-negative patients diagnosed with esophageal candidiasis between January 1991 and December 1997.
- Diagnosis of esophageal candidiasis was confirmed through endoscopic and histological examination.
- Multivariate analysis was employed to assess the association between various factors (neoplasms, antibiotic, steroid, and omeprazole therapy) and the occurrence of esophageal candidiasis.
Main Results:
- Fifty-one patients were diagnosed with esophageal candidiasis. A significant proportion had pre-existing chronic diseases (48 patients) or had received prior treatments with antibiotics (20), steroids (13), or omeprazole (14).
- Multivariate analysis revealed significant associations between esophageal candidiasis and neoplasm (OR, 5.50), antibiotic therapy (OR, 11.97), steroid therapy (OR, 35.52), and omeprazole therapy (OR, 18.23).
- The odds of developing Candida esophagitis were substantially increased with prior exposure to antibiotics, steroids, and particularly omeprazole.
Conclusions:
- Candida esophagitis is more likely to occur in patients with chronic diseases who have been treated with antibiotics, steroids, or omeprazole.
- The findings strongly support the hypothesis that omeprazole treatment contributes to the development of esophageal candidiasis.
- These results highlight the importance of considering medication history, including gastric acid inhibitors, in the management of patients with suspected Candida esophagitis.
Related Concept Videos
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Esophageal Strictures-I: Introduction
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Candidiasis
Esophageal Achalasia
Gastroesophageal Reflux Disease

